The LISA (Laser Ionization and Spectroscopy of Actinides) consortium has been training a new generation of experts in different fields of radioactive ion beam research and applications, with the underlying goal of improving our knowledge of the elements known as the actinides using laser spectroscopy techniques.
Within the scope of the LISA Final conference, which is a gathering of the LISA MSCA innovative training network and beyond, we are pleased to invite you to a public lecture, given by Professor Adrian Merlo.
Professor Merlo studied medicine at the universities of Fribourg and Zurich from 1977 to 1983. He passed the medical state examination in 1983 and received his doctorate in the same year. Between 1984 and 1993, he completed his practical training at the cantonal hospitals in Aarau, St. Gallen, and Basel, and in 1993 he received the title of specialist in neurosurgery. From 1993 to 1995, he completed a research fellowship in tumor molecular genetics at Johns Hopkins University in Baltimore (USA), after which he took a position as senior physician at the University Hospital Basel.
In 1998, he habilitated and was appointed as a private lecturer in neurosurgery at the University Hospital Basel. Also in 1998, Prof. Merlo took a position as chief physician for neurosurgery at the Cantonal Hospital Basel, and in 2001 he was appointed as an associate professor for neurosurgery at the University Hospital Basel. For his medical research, he was awarded the Cloëtta Prize in 2006.
From 2006 to 2008,Prof. Merlo was the acting chief physician of neurosurgery at the University Hospital Basel, and since September 2008, he has been running a neurosurgical practice in Bern.
Prof. Merlo will talk about the relevance of targeted alpha therapy for the treatment of gliomas, based on the radioactive isotope of Ac-225. Within LISA, production and extraction of this medically relevant isotope were investigated.
Please find some of Prof. Merlo's publications on this topic here: [1], [2]
Doors will open as of 5 pm.
